Search
for
Sort by
Research 721–750 of 1000+
- ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES
- NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
- N‑K GM SERIES: COMPLETE HAIR MEDICINES COLLECTION — From L‑Series Longevity to Dedicated Hair Restoration: BALDNESS-GM1, HAIR-REMOVE-GM1, and the Complete Hair Health Protocol
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- SUN-106 Nonsurgical Management of Hyperandrogenism in a Postmenopausal Woman
- Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges.
- Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
- Molecular docking study of phytochemical compounds from Kustakudori ennai as a potential anti-alopecia treatment
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Expanding the therapeutic versatility of clacosterone
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Androgenic Alopecia and Homoeopathic Management
- Needle Transportable Semi-Automatic Hair Follicle Implanter and Image-Based Hair Density Estimation for Advanced Hair Transplantation Surgery
- Тіе Modern treatment of androgenetic alopecia
- Androgen synthesis, metabolism and action in the developing ovarian follicle
- Ruolo dei neurosteroidi nella modulazione dopaminergica
- Myocyte Androgen Receptor Modulates Body Composition and Metabolic Parameters
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Therapie der androgenetischen Alopezie der Frau mit Minoxidil-Lösung
- [Hirsutism].
- Androgen Treatment in Women
- Cyproteronacetat zur topischen Therapie androgenabhängiger Erkrankungen
- Is there a link between androgenetic alopecia and COVID-19?
- 174 Changes in urine androgen and PG levels during finasteride treatment
- Male Androgenetic Alopecia — Endotext
- 16232 Analysis of androgen excess and association with polycystic ovary syndrome in female-pattern hair loss before 30 years of age
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- Male Accessory Sex Glands
- Gender differences in patients with COVID-19: a narrative review
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry